| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 07/16/2009 | US20090181043 Method for Producing Human Anti-Thymocyte Immunoglobulins |
| 07/16/2009 | US20090181042 Novel peptides of the respiratory syncytial virus (RSV) G protein and their use in a vaccine |
| 07/16/2009 | US20090181039 Conjugates with reduced adverse systemic effects |
| 07/16/2009 | US20090181037 Semi-Synthetic GLP-1 Peptide-FC Fusion Constructs, Methods and Uses |
| 07/16/2009 | US20090181035 Plexind1 agonists and their use |
| 07/16/2009 | US20090181034 Antibodies and related molecules that bind to psca proteins |
| 07/16/2009 | US20090181033 Antibodies for identifying and/or isolating at least one cell population |
| 07/16/2009 | US20090181032 facilitate drug delivery of other molecules; e.g. use intraocularly in eye surgery, glaucoma, retinopathy treatments |
| 07/16/2009 | US20090181030 Use of a preparation based on an antibody directed against a tumor-associated glycosylation |
| 07/16/2009 | US20090181029 Methods for treating interleukin-6 related diseases |
| 07/16/2009 | US20090181025 T Cell Adhesion Molecule and Antibody Thereto |
| 07/16/2009 | US20090181024 Novel composition and methods for the treatment of immune related diseases |
| 07/16/2009 | US20090181023 Nogo-a binding with enhanced affinity and pharmaceutical use thereof |
| 07/16/2009 | US20090181022 Bispecific binding agents for modulating biological activity |
| 07/16/2009 | US20090181021 Ctsp Cancer-Testis Antigens |
| 07/16/2009 | US20090181018 Humanized anti-ghrelin antibodies |
| 07/16/2009 | US20090181015 Humanized anti-cd40 antibodies and their methods of use |
| 07/16/2009 | US20090181014 Compositions and methods for the diagnosis and treatment of tumor |
| 07/16/2009 | US20090181013 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 07/16/2009 | US20090181011 Compounds, Compositions and Methods for the Endocytic Presentation of Immunosuppressive Factors |
| 07/16/2009 | US20090181009 treats hematologic malignancies, cancer; scFv antibody |
| 07/16/2009 | US20090181003 Regulation of S6 Kinsase Protein Activity and Related Methods |
| 07/16/2009 | US20090180995 Novel anticoagulant polypeptides and complex |
| 07/16/2009 | US20090180952 Ligands binding the complex of urokinase-type plasminogen activator (uppa) and its receptor (upar) that inhibit downstream upar interactions: identification and use in diagnosis or therapy |
| 07/16/2009 | CA2711882A1 Improved humanized anti-human .alpha.9-integrin antibody |
| 07/16/2009 | CA2711863A1 Antibody directed against pcrv |
| 07/16/2009 | CA2711771A1 Humanized anti-a9 integrin antibodies and the uses thereof |
| 07/16/2009 | CA2711691A1 Barb4 target, antibody designated barb4, barb4 related antibodies, and methods of making and using same |
| 07/16/2009 | CA2711557A1 Anti-cldn6 antibody |
| 07/16/2009 | CA2711497A1 Diagnostic and therapeutic methods for efmr (epilepsy and mental retardation limited to females) |
| 07/16/2009 | CA2711394A1 Cadherin-11 antagonists and methods for the treatment of inflammatory joint disorders |
| 07/16/2009 | CA2711334A1 Hemagglutinin polypeptides, and reagents and methods relating thereto |
| 07/16/2009 | CA2711307A1 Glycosylated protein expression in prokaryotes |
| 07/16/2009 | CA2711029A1 Anti mif antibodies |
| 07/16/2009 | CA2710922A1 Isomerases, nucleic acids encoding them and methods for making and using them |
| 07/16/2009 | CA2710683A1 Transferases and oxidoreductases, nucleic acids encoding them and methods for making and using them |
| 07/16/2009 | CA2709847A1 Method for making antibody fc-heterodimeric molecules using electrostatic steering effects |
| 07/15/2009 | EP2078752A2 ALK-1 responds to TGF-beta and signals through SMAD-1 and SMAD-5 |
| 07/15/2009 | EP2078732A1 Method of classifying antigen, method of identifying antigen, method of obtaining antibody or antibody set, method of constructing antibody panel and antibody or antibody set and use of the same |
| 07/15/2009 | EP2078731A1 Pharmaceutical composition comprising anti-hb-egf antibody as active ingredient |
| 07/15/2009 | EP2078531A2 Pharmaceutical compositions and methods useful for modulating angiogenesis |
| 07/15/2009 | EP2078200A1 Test for h. pylori infection |
| 07/15/2009 | EP2078196A2 Assay for the detection of phosphorylated pth |
| 07/15/2009 | EP2078091A2 CRYSTALS AND STRUCTURE OF HUMAN IgG Fc VARIANT |
| 07/15/2009 | EP2078075A2 Random homozygous gene perturbation to enhance antibody production |
| 07/15/2009 | EP2078041A2 Fusion proteins comprising two or more igg binding domains of streptococcal protein g. |
| 07/15/2009 | EP2078040A2 Hybrid immunoglobulins with moving parts |
| 07/15/2009 | EP2078037A1 Thyrotropin releasing hormone receptor-orexin receptor hetero-dimers/-oligomers |
| 07/15/2009 | EP2077859A2 Antibody formulation |
| 07/15/2009 | EP2006305A9 Modified antibody with enhanced bioactivity |
| 07/15/2009 | EP1877569A4 Predicting treatment response in cancer subjects |
| 07/15/2009 | EP1519746B1 Use of digoxin immune fab for the regulation of sodium/potassium atpase activity in preeclamptic and eclamptic patients |
| 07/15/2009 | EP1395278B1 Ocular tear growth factor-like protein |
| 07/15/2009 | EP1268802B1 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 07/15/2009 | EP1259249B1 Method for detecting the presence of target bacteria or a target component carbohydrate antigen thereof |
| 07/15/2009 | EP1115862B1 Cytokine receptor zalpha11 |
| 07/15/2009 | EP1075272B1 Methods for treating diabetes by inhibiting gdf-8 |
| 07/15/2009 | CN101484471A Anti-NKG2A antibodies and uses thereof |
| 07/15/2009 | CN101484470A Antibodies with enhanced antibody-dependent cellular cytoxicity activity, methods of their production and use |
| 07/15/2009 | CN101481417A Antihuman CD34 humanized antibody, preparation and use thereof |
| 07/15/2009 | CN101481416A Anti-scallop AVND virus monoclonal antibody, preparation and use thereof |
| 07/15/2009 | CN100513571C Recombinant helicobacter pylori catalase |
| 07/15/2009 | CN100513570C Regulation effect of conjugated frame transport protein ABC1 |
| 07/15/2009 | CN100513569C Recombinant helicobacter pylori heat shock protein 60 |
| 07/15/2009 | CN100513565C Apoptin-associating protein |
| 07/15/2009 | CN100513424C Recombination enterovirus 71 type neutralization antibudy and its use |
| 07/15/2009 | CN100513422C Parathyroid hormone-like polypeptides |
| 07/15/2009 | CN100513414C A system for antibody expression and assembly |
| 07/14/2009 | US7560540 Nucleotide sequences coding B7 immune response regulatory protein selectively expressed on dendritic cells for use as therapeutic tool in targeting viral and tumor cell for destruction |
| 07/14/2009 | US7560537 Human sarcoma-associated antigens |
| 07/14/2009 | US7560534 For use in therapeutic and diagnostic procedures |
| 07/14/2009 | US7560533 Binding compounds specific for cysteine-rich soluble protein C23 |
| 07/14/2009 | US7560532 Smad6 and uses thereof |
| 07/14/2009 | US7560531 Cln101 antibody compositions and methods of use alone and in combination with prostate specific antigen and other cancer markers |
| 07/14/2009 | US7560529 Method for producing catalytic antibodies (variants), antigens for immunization and nucleotide sequence |
| 07/14/2009 | US7560287 Long wavelength engineered fluorescent proteins |
| 07/14/2009 | US7560279 Method of proliferating human hepatocytes and method for obtaining human hepatocytes |
| 07/14/2009 | US7560253 Detecting level of expression of a hemopoietic linkage switch-5 (HLS-5) polynucleotide in a biological sample from a suspected or known cancer patient |
| 07/14/2009 | US7560247 Nucleic acids encoding anti-IL-12 antibodies, and methods of production |
| 07/14/2009 | US7560242 Metadherin polypeptides, encoding nucleic acids and methods of use |
| 07/14/2009 | US7560116 Compositions, methods and kits relating to poxvirus subunit vaccines |
| 07/14/2009 | US7560112 Anti-il-6 antibodies, compositions, methods and uses |
| 07/14/2009 | US7560111 HER2 antibody composition |
| 07/14/2009 | US7560110 Radioimmunotherapy; antibody fragment having at least one arm that specifically binds a targeted tissue and at least one other arm that specifically binds a targetable construct |
| 07/14/2009 | US7560109 Immunogen adherence inhibitor directed to lactic acid producing organisms and method of making and using it |
| 07/14/2009 | US7560108 Anti-TNFα antibodies |
| 07/14/2009 | US7560095 Cancer specific monoclonal antibodies |
| 07/14/2009 | CA2439858C Graft rejection suppressors |
| 07/14/2009 | CA2382302C A nucleic acid and encoding polypeptide for use in inhibiting tumor angiogenesis |
| 07/14/2009 | CA2331410C Methods for treating diabetes by inhibiting gdf-8 |
| 07/09/2009 | WO2009086539A2 Treatment and prophylaxis of amyloidosis |
| 07/09/2009 | WO2009086514A1 Humanized monoclonal antibodies and methods of use |
| 07/09/2009 | WO2009086411A2 Negative mimic antibody for use as a blocking reagent in bnp immunoassays |
| 07/09/2009 | WO2009086398A2 Anti-t. cruzi antibodies and methods of use |
| 07/09/2009 | WO2009086352A2 Cynomolgus toll-like receptor 3 |
| 07/09/2009 | WO2009086324A1 Anti-hedgehog antibodies |
| 07/09/2009 | WO2009086320A1 Fc variants with altered binding to fcrn |
| 07/09/2009 | WO2009086132A2 Design of spacers to increase the expression of recombinant fusion proteins |
| 07/09/2009 | WO2009086125A2 Affinity tag nucleic acid and protein compositions, and processes for using same |
| 07/09/2009 | WO2009086072A2 Therapy of rituximab-refractory rheumatoid arthritis patients |